True Vision MN LLC Acquires 10,863 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

True Vision MN LLC increased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 41.5% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 37,030 shares of the pharmacy operator’s stock after purchasing an additional 10,863 shares during the period. True Vision MN LLC’s holdings in Walgreens Boots Alliance were worth $332,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. Inlet Private Wealth LLC grew its stake in shares of Walgreens Boots Alliance by 1.9% in the second quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock worth $578,000 after acquiring an additional 900 shares during the period. Capital Investment Counsel Inc grew its position in Walgreens Boots Alliance by 6.6% in the 2nd quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator’s stock worth $186,000 after purchasing an additional 950 shares during the period. Continuum Advisory LLC lifted its holdings in shares of Walgreens Boots Alliance by 71.2% during the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,020 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of Walgreens Boots Alliance by 1.6% in the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 65,690 shares of the pharmacy operator’s stock worth $795,000 after buying an additional 1,038 shares during the last quarter. Finally, Sequoia Financial Advisors LLC grew its holdings in shares of Walgreens Boots Alliance by 4.4% in the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock worth $226,000 after acquiring an additional 1,063 shares during the period. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 3.6 %

Shares of NASDAQ:WBA traded down $0.33 during trading on Wednesday, hitting $8.73. 17,438,130 shares of the company’s stock were exchanged, compared to its average volume of 19,856,136. The business’s 50-day simple moving average is $9.13 and its 200 day simple moving average is $11.39. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. During the same quarter last year, the business posted $0.67 earnings per share. The company’s revenue for the quarter was up 5.9% compared to the same quarter last year. As a group, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 11.45%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Analysts Set New Price Targets

WBA has been the topic of a number of recent research reports. Barclays increased their target price on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. Bank of America lowered their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research note on Wednesday, September 4th. Jefferies Financial Group cut their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. JPMorgan Chase & Co. dropped their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, August 30th. Finally, Morgan Stanley reduced their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.